LeMaitre Vascular, Inc. (LMAT)
USD 90.34
(-0.65%)
USD 90.34
(-0.65%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 346.77 Million USD | 11.69% |
| 2022 | 310.47 Million USD | 6.04% |
| 2021 | 292.8 Million USD | 15.82% |
| 2020 | 252.81 Million USD | 34.23% |
| 2019 | 188.33 Million USD | 23.03% |
| 2018 | 153.08 Million USD | 21.19% |
| 2017 | 126.32 Million USD | 23.94% |
| 2016 | 101.92 Million USD | 12.37% |
| 2015 | 90.7 Million USD | 11.3% |
| 2014 | 81.49 Million USD | 15.6% |
| 2013 | 70.49 Million USD | 11.79% |
| 2012 | 63.06 Million USD | 5.65% |
| 2011 | 59.68 Million USD | -5.67% |
| 2010 | 63.27 Million USD | 11.19% |
| 2009 | 56.9 Million USD | 4.61% |
| 2008 | 54.39 Million USD | -11.04% |
| 2007 | 61.15 Million USD | 7.35% |
| 2006 | 56.96 Million USD | 127.23% |
| 2005 | 25.06 Million USD | 22.28% |
| 2004 | 20.5 Million USD | 0.0% |
| 2002 | 12.71 Million USD | 4.57% |
| 2001 | 12.16 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 353.95 Million USD | 2.07% |
| 2024 Q2 | 363.07 Million USD | 2.58% |
| 2024 Q3 | 377.02 Million USD | 3.84% |
| 2023 Q4 | 346.77 Million USD | 3.82% |
| 2023 FY | 346.77 Million USD | 11.69% |
| 2023 Q1 | 314.86 Million USD | 1.41% |
| 2023 Q2 | 326.46 Million USD | 3.68% |
| 2023 Q3 | 334.01 Million USD | 2.31% |
| 2022 Q2 | 299.42 Million USD | 2.38% |
| 2022 Q3 | 302.04 Million USD | 0.88% |
| 2022 Q4 | 310.47 Million USD | 2.79% |
| 2022 Q1 | 292.45 Million USD | -0.12% |
| 2022 FY | 310.47 Million USD | 6.04% |
| 2021 Q4 | 292.8 Million USD | 1.15% |
| 2021 FY | 292.8 Million USD | 15.82% |
| 2021 Q1 | 247.36 Million USD | -2.15% |
| 2021 Q2 | 246.5 Million USD | -0.35% |
| 2021 Q3 | 289.47 Million USD | 17.43% |
| 2020 Q3 | 261.56 Million USD | 2.29% |
| 2020 Q4 | 252.81 Million USD | -3.35% |
| 2020 Q2 | 255.71 Million USD | 38.56% |
| 2020 Q1 | 184.55 Million USD | -2.01% |
| 2020 FY | 252.81 Million USD | 34.23% |
| 2019 FY | 188.33 Million USD | 23.03% |
| 2019 Q3 | 170.01 Million USD | 4.52% |
| 2019 Q4 | 188.33 Million USD | 10.78% |
| 2019 Q1 | 160.25 Million USD | 4.68% |
| 2019 Q2 | 162.66 Million USD | 1.5% |
| 2018 Q1 | 129.41 Million USD | 2.44% |
| 2018 Q3 | 144.32 Million USD | 5.27% |
| 2018 Q4 | 153.08 Million USD | 6.07% |
| 2018 FY | 153.08 Million USD | 21.19% |
| 2018 Q2 | 137.1 Million USD | 5.94% |
| 2017 Q3 | 121.26 Million USD | 8.22% |
| 2017 Q1 | 106.52 Million USD | 4.51% |
| 2017 FY | 126.32 Million USD | 23.94% |
| 2017 Q4 | 126.32 Million USD | 4.17% |
| 2017 Q2 | 112.05 Million USD | 5.19% |
| 2016 Q4 | 101.92 Million USD | 0.61% |
| 2016 FY | 101.92 Million USD | 12.37% |
| 2016 Q3 | 101.3 Million USD | 6.05% |
| 2016 Q2 | 95.52 Million USD | 2.3% |
| 2016 Q1 | 93.38 Million USD | 2.95% |
| 2015 Q2 | 83.23 Million USD | 4.6% |
| 2015 Q1 | 79.57 Million USD | -2.35% |
| 2015 Q4 | 90.7 Million USD | 4.72% |
| 2015 FY | 90.7 Million USD | 11.3% |
| 2015 Q3 | 86.61 Million USD | 4.05% |
| 2014 Q1 | 68.71 Million USD | -2.52% |
| 2014 FY | 81.49 Million USD | 15.6% |
| 2014 Q2 | 80.53 Million USD | 17.2% |
| 2014 Q3 | 83.4 Million USD | 3.56% |
| 2014 Q4 | 81.49 Million USD | -2.29% |
| 2013 Q4 | 70.49 Million USD | 5.85% |
| 2013 Q1 | 63.24 Million USD | 0.29% |
| 2013 Q2 | 63.67 Million USD | 0.68% |
| 2013 Q3 | 66.59 Million USD | 4.59% |
| 2013 FY | 70.49 Million USD | 11.79% |
| 2012 FY | 63.06 Million USD | 5.65% |
| 2012 Q4 | 63.06 Million USD | 3.05% |
| 2012 Q2 | 59.99 Million USD | 1.03% |
| 2012 Q3 | 61.19 Million USD | 1.99% |
| 2012 Q1 | 59.38 Million USD | -0.5% |
| 2011 Q4 | 59.68 Million USD | -5.29% |
| 2011 Q1 | 61.05 Million USD | -3.51% |
| 2011 Q2 | 61.69 Million USD | 1.05% |
| 2011 Q3 | 63.02 Million USD | 2.16% |
| 2011 FY | 59.68 Million USD | -5.67% |
| 2010 FY | 63.27 Million USD | 11.19% |
| 2010 Q3 | 61.43 Million USD | 5.84% |
| 2010 Q2 | 58.04 Million USD | 1.93% |
| 2010 Q1 | 56.95 Million USD | 0.08% |
| 2010 Q4 | 63.27 Million USD | 2.99% |
| 2009 Q4 | 56.9 Million USD | 1.04% |
| 2009 FY | 56.9 Million USD | 4.61% |
| 2009 Q2 | 53.7 Million USD | 5.53% |
| 2009 Q1 | 50.89 Million USD | -6.45% |
| 2009 Q3 | 56.31 Million USD | 4.87% |
| 2008 Q1 | 56.78 Million USD | -7.14% |
| 2008 FY | 54.39 Million USD | -11.04% |
| 2008 Q4 | 54.39 Million USD | 1.55% |
| 2008 Q3 | 53.57 Million USD | -4.39% |
| 2008 Q2 | 56.02 Million USD | -1.33% |
| 2007 FY | 61.15 Million USD | 7.35% |
| 2007 Q1 | 55.96 Million USD | -1.75% |
| 2007 Q2 | 56.22 Million USD | 0.47% |
| 2007 Q3 | 57.09 Million USD | 1.54% |
| 2007 Q4 | 61.15 Million USD | 7.1% |
| 2006 FY | 56.96 Million USD | 127.23% |
| 2006 Q4 | 56.96 Million USD | 106.02% |
| 2006 Q3 | 27.64 Million USD | -0.12% |
| 2006 Q1 | 26.46 Million USD | 5.56% |
| 2006 Q2 | 27.68 Million USD | 4.61% |
| 2005 FY | 25.06 Million USD | 22.28% |
| 2005 Q4 | 25.06 Million USD | 0.0% |
| 2004 Q4 | 20.5 Million USD | 0.0% |
| 2004 FY | 20.5 Million USD | 0.0% |
| 2002 FY | 12.71 Million USD | 4.57% |
| 2001 FY | 12.16 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 180.36 Million USD | -92.26% |
| AngioDynamics, Inc. | 317.67 Million USD | -9.163% |
| AtriCure, Inc. | 613.93 Million USD | 43.515% |
| Avinger, Inc. | 13.77 Million USD | -2418.359% |
| Azenta, Inc. | 2.88 Billion USD | 87.983% |
| BioLife Solutions, Inc. | 412.71 Million USD | 15.976% |
| The Cooper Companies, Inc. | 11.65 Billion USD | 97.026% |
| Daxor Corporation | 34.86 Million USD | -894.513% |
| Ekso Bionics Holdings, Inc. | 28.91 Million USD | -1099.177% |
| Femasys Inc. | 27.75 Million USD | -1149.388% |
| GlucoTrack, Inc. | 4.9 Million USD | -6969.888% |
| Harvard Bioscience, Inc. | 137.36 Million USD | -152.448% |
| Hologic, Inc. | 9.15 Billion USD | 96.213% |
| ICU Medical, Inc. | 4.37 Billion USD | 92.08% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | 97.754% |
| KORU Medical Systems, Inc. | 28.46 Million USD | -1118.433% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -5476.319% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -5476.319% |
| Masimo Corporation | 3.04 Billion USD | 88.598% |
| Microbot Medical Inc. | 8.32 Million USD | -4064.501% |
| Meihua International Medical Technologies Co., Ltd. | 171.91 Million USD | -101.714% |
| Merit Medical Systems, Inc. | 2.32 Billion USD | 85.086% |
| Nephros, Inc. | 11.86 Million USD | -2823.683% |
| NovoCure Limited | 1.14 Billion USD | 69.744% |
| NEXGEL, Inc. | 9.95 Million USD | -3383.456% |
| NEXGEL, Inc. | 9.95 Million USD | -3383.456% |
| Singular Genomics Systems, Inc. | 265.46 Million USD | -30.629% |
| OraSure Technologies, Inc. | 482.84 Million USD | 28.18% |
| Pro-Dex, Inc. | 54.21 Million USD | -539.694% |
| Pulse Biosciences, Inc. | 60.8 Million USD | -470.321% |
| Predictive Oncology Inc. | 14.41 Million USD | -2305.299% |
| Precision Optics Corporation, Inc. | 16.91 Million USD | -1950.415% |
| QuidelOrtho Corporation | 8.56 Billion USD | 95.95% |
| Repligen Corporation | 2.82 Billion USD | 87.722% |
| Sanara MedTech Inc. | 73.87 Million USD | -369.436% |
| STAAR Surgical Company | 488.69 Million USD | 29.04% |
| Sharps Technology, Inc. | 11.78 Million USD | -2841.472% |
| Utah Medical Products, Inc. | 135.45 Million USD | -156.004% |
| DENTSPLY SIRONA Inc. | 7.37 Billion USD | 95.295% |
| Jin Medical International Ltd. | 32.9 Million USD | -953.926% |